|
Markt geschlossen -
Nasdaq
22:00:00 16.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 157.14 USD | -2.87% |
|
-6.66% | -13.96% |
| 14.10. | Axsome weist vor den Q3-Zahlen auf Bewertungsdiskrepanz hin, so RBC | MT |
| 08.10. | Axsome Therapeutics, Inc. : RBC Capital Markets bekräftigt seine Kaufempfehlung | ZM |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.87% | -6.66% | -25.87% | -33.71% | -13.96% | +25.71% | +134.85% | +291.87% | +2’055.56% | 8.23 Mrd. | |
| +0.43% | +6.59% | +10.48% | +7.51% | +16.97% | +53.41% | +103.85% | +428.43% | +1’485.76% | 1’120 Mrd. | |
| +0.90% | -2.25% | -4.38% | +2.24% | +23.49% | +33.02% | +62.23% | +58.44% | +117.39% | 616 Mrd. | |
| +0.71% | +3.24% | +8.73% | +12.20% | +24.92% | +25.81% | +93.86% | +161.06% | +374.36% | 504 Mrd. | |
| -0.13% | +5.98% | +4.61% | +14.35% | +15.54% | +32.91% | +50.39% | +5.26% | +60.81% | 367 Mrd. | |
| +0.52% | +0.24% | +0.72% | +14.35% | +38.66% | +73.92% | +40.15% | +86.33% | +134.87% | 360 Mrd. | |
| -0.95% | +4.70% | +9.12% | +1.17% | +13.78% | +19.51% | +43.00% | +62.10% | +65.38% | 288 Mrd. | |
| -1.98% | +3.73% | +2.55% | -1.44% | -9.75% | -0.86% | +13.43% | +41.51% | +151.59% | 258 Mrd. | |
| -0.35% | +4.25% | +14.92% | +16.39% | +32.13% | +46.21% | +50.76% | +108.09% | +167.13% | 234 Mrd. | |
| -0.75% | +3.32% | +5.76% | +14.59% | +27.25% | +32.53% | +97.21% | +130.95% | +114.69% | 194 Mrd. | |
| -1.46% | +1.70% | -4.77% | -22.69% | -20.18% | -29.07% | -63.28% | -21.09% | +91.94% | 173 Mrd. | |
| +0.48% | +4.60% | +7.72% | +17.66% | +18.80% | +22.08% | -11.09% | -28.71% | -9.43% | 169 Mrd. | |
| -1.77% | -2.03% | -2.63% | +2.82% | +10.23% | +22.30% | +33.62% | +174.93% | +530.75% | 127 Mrd. | |
| -1.35% | +1.07% | -6.05% | -1.26% | +10.77% | +37.70% | +4.51% | +2.38% | +20.05% | 122 Mrd. | |
| +0.62% | +7.03% | +13.25% | +19.44% | +22.50% | +29.58% | +120.70% | +392.16% | +524.12% | 117 Mrd. | |
| -0.32% | +6.43% | -0.16% | -4.78% | +2.08% | +13.98% | +24.73% | +6.46% | -11.89% | 99.56 Mrd. | |
| -0.30% | +0.59% | -3.24% | -6.50% | -13.03% | -16.67% | -30.75% | -14.19% | +5.02% | 96.96 Mrd. | |
| -7.82% | -3.11% | +49.71% | +245.23% | +639.27% | +703.28% | +137.12% | -32.76% | - | 87.04 Mrd. | |
| -0.70% | +5.92% | +2.08% | +16.47% | +2.44% | +38.93% | -6.27% | +42.93% | +112.75% | 78.96 Mrd. | |
| +0.73% | +4.68% | +9.57% | +4.60% | +17.70% | +29.01% | -3.38% | -24.98% | +47.94% | 70.58 Mrd. | |
| Durchschnitt | -0.51% | +2.64% | +4.60% | +15.93% | +42.98% | +59.67% | +44.78% | +93.56% | +317.83% | 254.47 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | -0.04% | +3.54% | +5.67% | +11.03% | +27.66% | +45.25% | +58.84% | +151.26% | +457.73% |
- Börse
- Aktien
- A2AA7B Aktie
- Sektor Axsome Therapeutics, Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
